{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:37:28Z","timestamp":1791013048631,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,11,20]],"date-time":"2007-11-20T00:00:00Z","timestamp":1195516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10585-007-9125-3","type":"journal-article","created":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T11:55:01Z","timestamp":1195473301000},"page":"149-159","source":"Crossref","is-referenced-by-count":114,"title":["Syndecan-1: a dynamic regulator of the myeloma microenvironment"],"prefix":"10.1007","volume":"25","author":[{"given":"Ralph D.","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,20]]},"reference":[{"key":"9125_CR1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","volume":"68","author":"M Bernfield","year":"1999","unstructured":"Bernfield M, Gotte M, Park PW et\u00a0al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729\u2013777","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"9125_CR2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.148.2.227","volume":"148","author":"AD Lander","year":"2000","unstructured":"Lander AD, Selleck SB (2000) The elusive functions of proteoglycans: in\u00a0vivo veritas. J Cell Biol 148(2):227\u2013232","journal-title":"J Cell Biol"},{"issue":"5","key":"9125_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0962-8924(98)01244-6","volume":"8","author":"A Woods","year":"1998","unstructured":"Woods A, Couchman JR (1998) Syndecans: synergistic activators of cell adhesion. Trends Cell Biol 8(5):189\u2013192","journal-title":"Trends Cell Biol"},{"issue":"3","key":"9125_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI200113738","volume":"108","author":"RV Iozzo","year":"2001","unstructured":"Iozzo RV, San Antonio JD (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108(3):349\u2013355","journal-title":"J Clin Invest"},{"issue":"7139","key":"9125_CR5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","volume":"446","author":"JR Bishop","year":"2007","unstructured":"Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446(7139):1030\u20131037","journal-title":"Nature"},{"issue":"5","key":"9125_CR6","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1021\/bi011944j","volume":"41","author":"B Goger","year":"2002","unstructured":"Goger B, Halden Y, Rek A et\u00a0al (2002) Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41(5):1640\u20131646","journal-title":"Biochemistry"},{"issue":"3","key":"9125_CR7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-4652(199803)174:3<310::AID-JCP5>3.0.CO;2-R","volume":"174","author":"MS Filla","year":"1998","unstructured":"Filla MS, Dam P, Rapraeger AC (1998) The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J Cell Physiol 174(3):310\u2013321","journal-title":"J Cell Physiol"},{"issue":"2","key":"9125_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/scdb.2000.0237","volume":"12","author":"N Perrimon","year":"2001","unstructured":"Perrimon N, Bernfield M (2001) Cellular functions of proteoglycans\u2013an overview. Semin Cell Dev Biol 12(2):65\u201367","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"9125_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc842","volume":"2","author":"R Sasisekharan","year":"2002","unstructured":"Sasisekharan R, Shriver Z, Venkataraman G et\u00a0al (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2(7):521\u2013528","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"9125_CR10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1054\/bjoc.2001.2054","volume":"85","author":"FH Blackhall","year":"2001","unstructured":"Blackhall FH, Merry CL, Davies EJ et\u00a0al (2001) Heparan sulfate proteoglycans and cancer. Br J Cancer 85(8):1094\u20131098","journal-title":"Br J Cancer"},{"issue":"7","key":"9125_CR11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.matbio.2006.07.003","volume":"25","author":"CY Fears","year":"2006","unstructured":"Fears CY, Woods A (2006) The role of syndecans in disease and wound healing. Matrix Biol 25(7):443\u2013456","journal-title":"Matrix Biol"},{"issue":"1","key":"9125_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7827-2-3","volume":"2","author":"DM Beauvais","year":"2004","unstructured":"Beauvais DM, Rapraeger AC (2004) Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2(1):3","journal-title":"Reprod Biol Endocrinol"},{"issue":"4869","key":"9125_CR13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.3137658","volume":"241","author":"JD Esko","year":"1988","unstructured":"Esko JD, Rostand KS, Weinke JL (1988) Tumor formation dependent on proteoglycan biosynthesis. Science 241(4869):1092\u20131096","journal-title":"Science"},{"issue":"3","key":"9125_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/77108","volume":"25","author":"CM Alexander","year":"2000","unstructured":"Alexander CM, Reichsman F, Hinkes MT et\u00a0al (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25(3):329\u2013332","journal-title":"Nat Genet"},{"issue":"6779","key":"9125_CR15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/35008000","volume":"404","author":"N Perrimon","year":"2000","unstructured":"Perrimon N, Bernfield M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404(6779):725\u2013728","journal-title":"Nature"},{"issue":"14","key":"9125_CR16","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","volume":"65","author":"MI Capurro","year":"2005","unstructured":"Capurro MI, Xiang YY, Lobe C et\u00a0al (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 65(14):6245\u20136254","journal-title":"Cancer Res"},{"issue":"8","key":"9125_CR17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1172\/JCI3793","volume":"102","author":"B Sharma","year":"1998","unstructured":"Sharma B, Handler M, Eichstetter I et\u00a0al (1998) Antisense targeting of perlecan blocks tumor growth and angiogenesis in\u00a0vivo. J Clin Invest 102(8):1599\u20131608","journal-title":"J Clin Invest"},{"issue":"11","key":"9125_CR18","first-page":"2130","volume":"57","author":"M Mathiak","year":"1997","unstructured":"Mathiak M, Yenisey C, Grant DS et\u00a0al (1997) A role for perlecan in the suppression of growth and invasion in fibrocarcinoma cells. Cancer Res 57(11):2130\u20132136","journal-title":"Cancer Res"},{"issue":"5","key":"9125_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10585-005-2339-3","volume":"22","author":"C Savore","year":"2005","unstructured":"Savore C, Zhang C, Muir C et\u00a0al (2005) Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in\u00a0vitro and tumor growth in\u00a0vivo. Clin Exp Metastasis 22(5):377\u2013390","journal-title":"Clin Exp Metastasis"},{"key":"9125_CR20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2141.1997.3893203.x","volume":"99","author":"MV Dhodapkar","year":"1997","unstructured":"Dhodapkar MV, Kelly T, Theus A et\u00a0al (1997) Elevated levels of shed syndecan-1 correlate with tumor mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma. Br J Hematol 99:368\u2013371","journal-title":"Br J Hematol"},{"issue":"18","key":"9125_CR21","first-page":"5210","volume":"62","author":"H Joensuu","year":"2002","unstructured":"Joensuu H, Anttonen A, Eriksson M et\u00a0al (2002) Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 62(18):5210\u20135217","journal-title":"Cancer Res"},{"issue":"9","key":"9125_CR22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI4105","volume":"102","author":"J Kleeff","year":"1998","unstructured":"Kleeff J, Ishiwata T, Kumbasar A et\u00a0al (1998) The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 102(9):1662\u20131673","journal-title":"J Clin Invest"},{"issue":"14","key":"9125_CR23","first-page":"5562","volume":"61","author":"K Matsuda","year":"2001","unstructured":"Matsuda K, Maruyama H, Guo F et\u00a0al (2001) Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61(14):5562\u20135569","journal-title":"Cancer Res"},{"issue":"2","key":"9125_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/scdb.2000.0241","volume":"12","author":"RD Sanderson","year":"2001","unstructured":"Sanderson RD (2001) Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol 12(2):89\u201398","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"9125_CR25","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1074\/jbc.275.6.4183","volume":"275","author":"WH Yu","year":"2000","unstructured":"Yu WH, Woessner JF Jr (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275(6):4183\u20134191","journal-title":"J Biol Chem"},{"key":"9125_CR26","doi-asserted-by":"crossref","first-page":"20013","DOI":"10.1016\/S0021-9258(17)32120-8","volume":"269","author":"BF Liebersbach","year":"1994","unstructured":"Liebersbach BF, Sanderson RD (1994) Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem 269:20013\u201320019","journal-title":"J Biol Chem"},{"issue":"6","key":"9125_CR27","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","volume":"98","author":"L Borsig","year":"2001","unstructured":"Borsig L, Wong R, Feramisco J et\u00a0al (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98(6):3352\u20133357","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9125_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0962-8924(00)01897-3","volume":"11","author":"J Turnbull","year":"2001","unstructured":"Turnbull J, Powell A, Guimond S (2001) Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11(2):75\u201382","journal-title":"Trends Cell Biol"},{"issue":"5","key":"9125_CR29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-9525(00)01997-1","volume":"16","author":"SB Selleck","year":"2000","unstructured":"Selleck SB (2000) Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. Trends Genet 16(5):206\u2013212","journal-title":"Trends Genet"},{"issue":"3","key":"9125_CR30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI13713","volume":"108","author":"JT Gallagher","year":"2001","unstructured":"Gallagher JT (2001) Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108(3):357\u2013361","journal-title":"J Clin Invest"},{"issue":"39","key":"9125_CR31","doi-asserted-by":"crossref","first-page":"24979","DOI":"10.1074\/jbc.273.39.24979","volume":"273","author":"U Lindahl","year":"1998","unstructured":"Lindahl U, Kusche-Gullberg M, Kjellen L (1998) Regulated diversity of heparan sulfate. J Biol Chem 273(39):24979\u201324982","journal-title":"J Biol Chem"},{"issue":"6","key":"9125_CR32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1367-5931(00)00145-9","volume":"4","author":"R Sasisekharan","year":"2000","unstructured":"Sasisekharan R, Venkataraman G (2000) Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol 4(6):626\u2013631","journal-title":"Curr Opin Chem Biol"},{"key":"9125_CR33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0006-291X(75)90708-1","volume":"63","author":"CB Underhill","year":"1975","unstructured":"Underhill CB, Keller JM (1975) A transformation-dependent difference in the heparan sulfate associated with the cell surface. Biochem Biophys Res Commun 63:448\u2013454","journal-title":"Biochem Biophys Res Commun"},{"key":"9125_CR34","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1016\/S0021-9258(17)34664-1","volume":"253","author":"DJ Winterbourne","year":"1978","unstructured":"Winterbourne DJ, Mora PT (1978) Altered metabolism of heparan sulphate in simian virus 40 transformed cloned mouse cells. J Biol Chem 253:5109\u20135120","journal-title":"J Biol Chem"},{"issue":"12","key":"9125_CR35","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1016\/S0021-9258(18)32183-5","volume":"258","author":"G David","year":"1983","unstructured":"David G, Van Den Berghe H (1983) Transformed mouse mammary epithelial cells synthesize undersulfated basement membrane proteoglycan. J Biol Chem 258(12):7338\u20137344","journal-title":"J Biol Chem"},{"key":"9125_CR36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1083\/jcb.98.3.946","volume":"98","author":"J Robinson","year":"1984","unstructured":"Robinson J, Viti M, H\u00f6\u00f6k M (1984) Structure and properties of an under-sulfated heparan sulfate proteoglycan synthesized by a rat hepatoma cell line. J Cell Biol 98:946\u2013953","journal-title":"J Cell Biol"},{"issue":"18","key":"9125_CR37","doi-asserted-by":"crossref","first-page":"13100","DOI":"10.1016\/S0021-9258(17)36804-7","volume":"269","author":"RD Sanderson","year":"1994","unstructured":"Sanderson RD, Turnbull JE, Gallagher JT et\u00a0al (1994) Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem 269(18):13100\u201313106","journal-title":"J Biol Chem"},{"issue":"1","key":"9125_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.273.1.51","volume":"273","author":"GC Jayson","year":"1998","unstructured":"Jayson GC, Lyon M, Paraskeva C et\u00a0al (1998) Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in\u00a0vitro. J Biol Chem 273(1):51\u201357","journal-title":"J Biol Chem"},{"issue":"3","key":"9125_CR39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1432-1327.1998.2520576.x","volume":"252","author":"F Safaiyan","year":"1998","unstructured":"Safaiyan F, Lindahl U, Salmivirta M (1998) Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells. Eur J Biochem 252(3):576\u2013582","journal-title":"Eur J Biochem"},{"issue":"7","key":"9125_CR40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/10518","volume":"5","author":"I Vlodavsky","year":"1999","unstructured":"Vlodavsky I, Friedmann Y, Elkin M et\u00a0al (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5(7):793\u2013802","journal-title":"Nat Med"},{"issue":"1","key":"9125_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/bbrc.1999.0962","volume":"261","author":"PH Kussie","year":"1999","unstructured":"Kussie PH, Hulmes JD, Ludwig DL et\u00a0al (1999) Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 261(1):183\u2013187","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"9125_CR42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/10525","volume":"5","author":"MD Hulett","year":"1999","unstructured":"Hulett MD, Freeman C, Hamdorf BJ et\u00a0al (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5(7):803\u2013809","journal-title":"Nat Med"},{"issue":"34","key":"9125_CR43","doi-asserted-by":"crossref","first-page":"24153","DOI":"10.1074\/jbc.274.34.24153","volume":"274","author":"M Toyoshima","year":"1999","unstructured":"Toyoshima M, Nakajima M (1999) Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274(34):24153\u201324160","journal-title":"J Biol Chem"},{"issue":"3","key":"9125_CR44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","volume":"108","author":"I Vlodavsky","year":"2001","unstructured":"Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108(3):341\u2013347","journal-title":"J Clin Invest"},{"issue":"1","key":"9125_CR45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0301-472X(01)00766-4","volume":"30","author":"M Bitan","year":"2002","unstructured":"Bitan M, Polliack A, Zecchina G et\u00a0al (2002) Heparanase expression in human leukemias is restricted to acute myeloid leukemias. Exp Hematol 30(1):34\u201341","journal-title":"Exp Hematol"},{"issue":"6","key":"9125_CR46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nm0698-691","volume":"4","author":"M Kato","year":"1998","unstructured":"Kato M, Wang H, Kainulainen V et\u00a0al (1998) Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med 4(6):691\u2013697","journal-title":"Nat Med"},{"issue":"2","key":"9125_CR47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/scbi.2001.0420","volume":"12","author":"I Vlodavsky","year":"2002","unstructured":"Vlodavsky I, Goldshmidt O, Zcharia E et\u00a0al (2002) Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12(2):121\u2013129","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"9125_CR48","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","volume":"38","author":"N Ilan","year":"2006","unstructured":"Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38(12):2018\u20132039","journal-title":"Int J Biochem Cell Biol"},{"issue":"17","key":"9125_CR49","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1074\/jbc.271.17.10079","volume":"271","author":"JM Whitelock","year":"1996","unstructured":"Whitelock JM, Murdoch AD, Iozzo RV et\u00a0al (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271(17):10079\u201310086","journal-title":"J Biol Chem"},{"issue":"9","key":"9125_CR50","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1096\/fj.00-0895fje","volume":"15","author":"M Elkin","year":"2001","unstructured":"Elkin M, Ilan N, Ishai-Michaeli R et\u00a0al (2001) Heparanase as mediator of angiogenesis: mode of action. FASEB J 15(9):1661\u20131663","journal-title":"FASEB J"},{"issue":"39","key":"9125_CR51","doi-asserted-by":"crossref","first-page":"33141","DOI":"10.1074\/jbc.M503007200","volume":"280","author":"V Vreys","year":"2005","unstructured":"Vreys V, Delande N, Zhang Z et\u00a0al (2005) Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans. J Biol Chem 280(39):33141\u201333148","journal-title":"J Biol Chem"},{"issue":"19","key":"9125_CR52","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1074\/jbc.270.19.11322","volume":"270","author":"T Cohen","year":"1995","unstructured":"Cohen T, Gitay-Goren H, Sharon R et\u00a0al (1995) VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270(19):11322\u201311326","journal-title":"J Biol Chem"},{"issue":"9","key":"9125_CR53","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1016\/S0021-9258(18)42666-X","volume":"267","author":"H Gitay-Goren","year":"1992","unstructured":"Gitay-Goren H, Soker S, Vlodavsky I et\u00a0al (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267(9):6093\u20136098","journal-title":"J Biol Chem"},{"issue":"1","key":"9125_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977199509003208","volume":"12","author":"MK Chiang","year":"1995","unstructured":"Chiang MK, Flanagan JG (1995) Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors 12(1):1\u201310","journal-title":"Growth Factors"},{"issue":"4","key":"9125_CR55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/08977199709021524","volume":"14","author":"AM Dougher","year":"1997","unstructured":"Dougher AM, Wasserstrom H, Torley L et\u00a0al (1997) Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 14(4):257\u2013268","journal-title":"Growth Factors"},{"issue":"3","key":"9125_CR56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1083\/jcb.200610086","volume":"177","author":"MM Fuster","year":"2007","unstructured":"Fuster MM, Wang L, Castagnola J et\u00a0al (2007) Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol 177(3):539\u2013549","journal-title":"J Cell Biol"},{"issue":"20","key":"9125_CR57","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1101\/gad.242002","volume":"16","author":"C Ruhrberg","year":"2002","unstructured":"Ruhrberg C, Gerhardt H, Golding M et\u00a0al (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16(20):2684\u20132698","journal-title":"Genes Dev"},{"issue":"16","key":"9125_CR58","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1074\/jbc.274.16.10816","volume":"274","author":"S Gengrinovitch","year":"1999","unstructured":"Gengrinovitch S, Berman B, David G et\u00a0al (1999) Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem 274(16):10816\u201310822","journal-title":"J Biol Chem"},{"issue":"2","key":"9125_CR59","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1083\/jcb.200212083","volume":"162","author":"X Ai","year":"2003","unstructured":"Ai X, Do AT, Lozynska O et\u00a0al (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162(2):341\u2013351","journal-title":"J Cell Biol"},{"issue":"5535","key":"9125_CR60","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.293.5535.1663","volume":"293","author":"GK Dhoot","year":"2001","unstructured":"Dhoot GK, Gustafsson MK, Ai X et\u00a0al (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293(5535):1663\u20131666","journal-title":"Science"},{"issue":"51","key":"9125_CR61","doi-asserted-by":"crossref","first-page":"49175","DOI":"10.1074\/jbc.M205131200","volume":"277","author":"M Morimoto-Tomita","year":"2002","unstructured":"Morimoto-Tomita M, Uchimura K, Werb Z et\u00a0al (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277(51):49175\u201349185","journal-title":"J Biol Chem"},{"issue":"7","key":"9125_CR62","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.onc.1207258","volume":"23","author":"JP Lai","year":"2004","unstructured":"Lai JP, Chien J, Strome SE et\u00a0al (2004) HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 23(7):1439\u20131447","journal-title":"Oncogene"},{"key":"9125_CR63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2091-7-2","volume":"7","author":"K Uchimura","year":"2006","unstructured":"Uchimura K, Morimoto-Tomita M, Bistrup A et\u00a0al (2006) HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem 7:2","journal-title":"BMC Biochem"},{"issue":"11","key":"9125_CR64","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1593\/neo.05496","volume":"7","author":"M Morimoto-Tomita","year":"2005","unstructured":"Morimoto-Tomita M, Uchimura K, Bistrup A et\u00a0al (2005) Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia 7(11):1001\u20131010","journal-title":"Neoplasia"},{"issue":"19","key":"9125_CR65","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.1074\/jbc.M611395200","volume":"282","author":"K Narita","year":"2007","unstructured":"Narita K, Chien J, Mullany SA et\u00a0al (2007) Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. J Biol Chem 282(19):14413\u201314420","journal-title":"J Biol Chem"},{"issue":"34","key":"9125_CR66","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/sj.onc.1210300","volume":"26","author":"J Staub","year":"2007","unstructured":"Staub J, Chien J, Pan Y et\u00a0al (2007) Epigenetic silencing of HSulf-1 in ovarian cancer: implications in chemoresistance. Oncogene 26(34):4969\u20134978","journal-title":"Oncogene"},{"issue":"1","key":"9125_CR67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2003.09.043","volume":"126","author":"JP Lai","year":"2004","unstructured":"Lai JP, Chien JR, Moser DR et\u00a0al (2004) hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 126(1):231\u2013248","journal-title":"Gastroenterology"},{"issue":"48","key":"9125_CR68","doi-asserted-by":"crossref","first-page":"40066","DOI":"10.1074\/jbc.M508136200","volume":"280","author":"Y Dai","year":"2005","unstructured":"Dai Y, Yang Y, MacLeod V et\u00a0al (2005) HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in\u00a0vivo. J Biol Chem 280(48):40066\u201340073","journal-title":"J Biol Chem"},{"key":"9125_CR69","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1083\/jcb.105.6.3087","volume":"105","author":"M Jalkanen","year":"1987","unstructured":"Jalkanen M, Rapraeger A, Saunders S et\u00a0al (1987) Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol 105:3087\u20133096","journal-title":"J Cell Biol"},{"issue":"6","key":"9125_CR70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.matbio.2004.08.004","volume":"23","author":"RD Sanderson","year":"2004","unstructured":"Sanderson RD, Yang Y, Suva LJ et\u00a0al (2004) Heparan sulfate proteoglycans and heparanase\u2013partners in osteolytic tumor growth and metastasis. Matrix Biol 23(6):341\u2013352","journal-title":"Matrix Biol"},{"issue":"5","key":"9125_CR71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(02)01079-6","volume":"111","author":"Q Li","year":"2002","unstructured":"Li Q, Park PW, Wilson CL et\u00a0al (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111(5):635\u2013646","journal-title":"Cell"},{"issue":"1","key":"9125_CR72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","volume":"125","author":"M Capurro","year":"2003","unstructured":"Capurro M, Wanless IR, Sherman M et\u00a0al (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125(1):89\u201397","journal-title":"Gastroenterology"},{"issue":"19","key":"9125_CR73","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/1078-0432.CCR-04-0348","volume":"10","author":"T Nakatsura","year":"2004","unstructured":"Nakatsura T, Kageshita T, Ito S et\u00a0al (2004) Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 10(19):6612\u20136621","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9125_CR74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00063030-200519020-00001","volume":"19","author":"T Nakatsura","year":"2005","unstructured":"Nakatsura T, Nishimura Y (2005) Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma. BioDrugs 19(2):71\u201377","journal-title":"BioDrugs"},{"issue":"2","key":"9125_CR75","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","volume":"95","author":"C Seidel","year":"2000","unstructured":"Seidel C, Sundan A, Hjorth M et\u00a0al (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood 95(2):388\u2013392","journal-title":"Blood"},{"issue":"2","key":"9125_CR76","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1073\/pnas.012578299","volume":"99","author":"D Liu","year":"2002","unstructured":"Liu D, Shriver Z, Venkataraman G et\u00a0al (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc Natl Acad Sci USA 99(2):568\u2013573","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"9125_CR77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/10409239509083490","volume":"30","author":"S Ernst","year":"1995","unstructured":"Ernst S, Langer R, Cooney CL et\u00a0al (1995) Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol 30(5):387\u2013444","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"Suppl 2","key":"9125_CR78","first-page":"1","volume":"13","author":"D Bergsagel","year":"1995","unstructured":"Bergsagel D (1995) The incidence and epidemiology of plasma cell neoplasms. Stem Cells 13(Suppl 2):1\u20139","journal-title":"Stem Cells"},{"key":"9125_CR79","volume-title":"Williams hematology","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Shaughnessy J, Epstein J et\u00a0al (2006) Plasma cell myeloma. In: Lichtman MA, Beutler E, Kipps TJ et\u00a0al (eds) Williams hematology, 7th edn. McGraw-Hill, New York","edition":"7"},{"issue":"3","key":"9125_CR80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","volume":"2","author":"WM Kuehl","year":"2002","unstructured":"Kuehl WM, Bergsagel PL (2002) Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2(3):175\u2013187","journal-title":"Nat Rev Cancer"},{"issue":"4 Suppl 1","key":"9125_CR81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.exphem.2007.01.024","volume":"35","author":"KC Anderson","year":"2007","unstructured":"Anderson KC (2007) Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions. Exp Hematol 35(4 Suppl 1):155\u2013162","journal-title":"Exp Hematol"},{"issue":"2","key":"9125_CR82","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0959-8049(97)10133-2","volume":"34","author":"GR Mundy","year":"1998","unstructured":"Mundy GR (1998) Myeloma bone disease. Eur J Cancer 34(2):246\u2013251","journal-title":"Eur J Cancer"},{"issue":"2","key":"9125_CR83","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bcmd.2004.01.001","volume":"32","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Pathogenesis of myeloma bone disease. Blood Cells Mol Dis 32(2):290\u2013292","journal-title":"Blood Cells Mol Dis"},{"issue":"8","key":"9125_CR84","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8):584\u2013593","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"9125_CR85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood.V81.3.767.767","volume":"81","author":"RC Ridley","year":"1993","unstructured":"Ridley RC, Xiao H, Hata H et\u00a0al (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81(3):767\u2013774","journal-title":"Blood"},{"issue":"2","key":"9125_CR86","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2141.1996.d01-1811.x","volume":"94","author":"J Wijdenes","year":"1996","unstructured":"Wijdenes J, Vooijs WC, Clement C et\u00a0al (1996) A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94(2):318\u2013323","journal-title":"Br J Haematol"},{"issue":"12","key":"9125_CR87","first-page":"1101","volume":"12","author":"M Chilosi","year":"1999","unstructured":"Chilosi M, Adami F, Lestani M et\u00a0al (1999) CD138\/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol 12(12):1101\u20131106","journal-title":"Mod Pathol"},{"issue":"10","key":"9125_CR88","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/modpathol.3880435","volume":"14","author":"IB Bayer-Garner","year":"2001","unstructured":"Bayer-Garner IB, Sanderson RD, Dhodapkar MV et\u00a0al (2001) Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod Pathol 14(10):1052\u20131058","journal-title":"Mod Pathol"},{"issue":"1\u20132","key":"9125_CR89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10428199809057596","volume":"31","author":"TE Witzig","year":"1998","unstructured":"Witzig TE, Kimlinger T, Stenson M et\u00a0al (1998) Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia. Leuk Lymphoma 31(1\u20132):167\u2013175","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"9125_CR90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1091\/mbc.1.1.27","volume":"1","author":"RD Sanderson","year":"1989","unstructured":"Sanderson RD, Lalor P, Bernfield M (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1(1):27\u201335","journal-title":"Cell Regul"},{"issue":"3","key":"9125_CR91","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1182\/blood-2002-06-1737","volume":"101","author":"F Zhan","year":"2003","unstructured":"Zhan F, Tian E, Bumm K et\u00a0al (2003) Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101(3):1128\u20131140","journal-title":"Blood"},{"issue":"12","key":"9125_CR92","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1182\/blood-2004-03-0963","volume":"104","author":"P Tassone","year":"2004","unstructured":"Tassone P, Goldmacher VS, Neri P et\u00a0al (2004) Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells. Blood 104(12):3688\u20133696","journal-title":"Blood"},{"issue":"4","key":"9125_CR93","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<571::AID-IJC21>3.0.CO;2-N","volume":"83","author":"J Post","year":"1999","unstructured":"Post J, Vooijs WC, Bast BJ et\u00a0al (1999) Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells. Int J Cancer 83(4):571\u2013576","journal-title":"Int J Cancer"},{"issue":"7","key":"9125_CR94","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002620100211","volume":"50","author":"L Ragnarsson","year":"2001","unstructured":"Ragnarsson L, Stromberg T, Wijdenes J et\u00a0al (2001) Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells. Cancer Immunol Immunother 50(7):382\u2013390","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"9125_CR95","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2005-05-2177","volume":"107","author":"EP Strandmann von","year":"2006","unstructured":"von Strandmann EP, Hansen HP, Reiners KS et\u00a0al (2006) A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in\u00a0vitro and in\u00a0vivo. Blood 107(5):1955\u20131962","journal-title":"Blood"},{"issue":"1","key":"9125_CR96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20011097","volume":"195","author":"KM Dhodapkar","year":"2002","unstructured":"Dhodapkar KM, Krasovsky J, Williamson B et\u00a0al (2002) Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J Exp Med 195(1):125\u2013133","journal-title":"J Exp Med"},{"issue":"2","key":"9125_CR97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1091\/mbc.12.2.339","volume":"12","author":"P Zimmermann","year":"2001","unstructured":"Zimmermann P, Tomatis D, Rosas M et\u00a0al (2001) Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Mol Biol Cell 12(2):339\u2013350","journal-title":"Mol Biol Cell"},{"key":"9125_CR98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7696(01)07004-8","volume":"207","author":"JR Couchman","year":"2001","unstructured":"Couchman JR, Chen L, Woods A (2001) Syndecans and cell adhesion. Int Rev Cytol 207:113\u2013150","journal-title":"Int Rev Cytol"},{"issue":"1","key":"9125_CR99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1083\/jcb.200404171","volume":"167","author":"DM Beauvais","year":"2004","unstructured":"Beauvais DM, Burbach BJ, Rapraeger AC (2004) The syndecan-1 ectodomain regulates alpha V beta 3 integrin activity in human mammary carcinoma cells. J Cell Biol 167(1):171\u2013181","journal-title":"J Cell Biol"},{"issue":"Pt 12","key":"9125_CR100","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1242\/jcs.02970","volume":"119","author":"KJ McQuade","year":"2006","unstructured":"McQuade KJ, Beauvais DM, Burbach BJ et\u00a0al (2006) Syndecan-1 regulates alpha V beta5 integrin activity in B82L fibroblasts. J Cell Sci 119(Pt 12):2445\u20132456","journal-title":"J Cell Sci"},{"issue":"4","key":"9125_CR101","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1523-1747.ep12616103","volume":"99","author":"RD Sanderson","year":"1992","unstructured":"Sanderson RD, Hinkes MT, Bernfield M (1992) Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 99(4):390\u2013396","journal-title":"J Invest Dermatol"},{"key":"9125_CR102","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1074\/jbc.270.10.5077","volume":"270","author":"MJ Stanley","year":"1995","unstructured":"Stanley MJ, Liebersbach BF, Liu W et\u00a0al (1995) Heparan sulfate-mediated cell aggregation: Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem 270:5077\u20135083","journal-title":"J Biol Chem"},{"issue":"23","key":"9125_CR103","doi-asserted-by":"crossref","first-page":"14713","DOI":"10.1074\/jbc.272.23.14713","volume":"272","author":"SV Subramanian","year":"1997","unstructured":"Subramanian SV, Fitzgerald ML, Bernfield M (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272(23):14713\u201314720","journal-title":"J Biol Chem"},{"issue":"4","key":"9125_CR104","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1083\/jcb.148.4.811","volume":"148","author":"ML Fitzgerald","year":"2000","unstructured":"Fitzgerald ML, Wang Z, Park PW et\u00a0al (2000) Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 148(4):811\u2013824","journal-title":"J Cell Biol"},{"issue":"4","key":"9125_CR105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.1998.00623.x","volume":"100","author":"M Jourdan","year":"1998","unstructured":"Jourdan M, Ferlin M, Legouffe E et\u00a0al (1998) The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells. Br J Haematol 100(4):637\u2013646","journal-title":"Br J Haematol"},{"issue":"4","key":"9125_CR106","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2141.2005.05647.x","volume":"130","author":"R Lovell","year":"2005","unstructured":"Lovell R, Dunn JA, Begum G et\u00a0al (2005) Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival. Br J Haematol 130(4):542\u2013548","journal-title":"Br J Haematol"},{"issue":"2","key":"9125_CR107","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V100.2.610","volume":"100","author":"Y Yang","year":"2002","unstructured":"Yang Y, Yaccoby S, Liu W et\u00a0al (2002) Soluble syndecan-1 promotes growth of myeloma tumors in\u00a0vivo. Blood 100(2):610\u2013617","journal-title":"Blood"},{"issue":"2","key":"9125_CR108","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.2004.05299.x","volume":"128","author":"NF Andersen","year":"2005","unstructured":"Andersen NF, Standal T, Nielsen JL et\u00a0al (2005) Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. Br J Haematol 128(2):210\u2013217","journal-title":"Br J Haematol"},{"issue":"20","key":"9125_CR109","doi-asserted-by":"crossref","first-page":"14906","DOI":"10.1074\/jbc.M611739200","volume":"282","author":"G Su","year":"2007","unstructured":"Su G, Blaine SA, Qiao D et\u00a0al (2007) Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J Biol Chem 282(20):14906\u201314915","journal-title":"J Biol Chem"},{"issue":"9","key":"9125_CR110","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/sj.onc.1209168","volume":"25","author":"T Maeda","year":"2006","unstructured":"Maeda T, Desouky J, Friedl A (2006) Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in\u00a0vivo and stimulates tumor angiogenesis. Oncogene 25(9):1408\u20131412","journal-title":"Oncogene"},{"key":"9125_CR111","doi-asserted-by":"crossref","first-page":"40764","DOI":"10.1074\/jbc.M306736200","volume":"278","author":"K Endo","year":"2003","unstructured":"Endo K, Takino T, Miyamori H et\u00a0al (2003) Cleavage of syndecan-1 by membrane-type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278:40764\u201340770","journal-title":"J Biol Chem"},{"issue":"6","key":"9125_CR112","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/glycob\/cwj098","volume":"16","author":"S Brule","year":"2006","unstructured":"Brule S, Charnaux N, Sutton A et\u00a0al (2006) The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1\/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 16(6):488\u2013501","journal-title":"Glycobiology"},{"issue":"2","key":"9125_CR113","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-2141.2001.02963.x","volume":"114","author":"I Holen","year":"2001","unstructured":"Holen I, Drury NL, Hargreaves PG et\u00a0al (2001) Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells. Br J Haematol 114(2):414\u2013421","journal-title":"Br J Haematol"},{"issue":"24","key":"9125_CR114","first-page":"8749","volume":"63","author":"T Kelly","year":"2003","unstructured":"Kelly T, Miao HQ, Yang Y et\u00a0al (2003) High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 63(24):8749\u20138756","journal-title":"Cancer Res"},{"issue":"3","key":"9125_CR115","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood-2004-06-2141","volume":"105","author":"Y Yang","year":"2005","unstructured":"Yang Y, Macleod V, Bendre M et\u00a0al (2005) Heparanase promotes the spontaneous metastasis of myeloma cells to bone. Blood 105(3):1303\u20131309","journal-title":"Blood"},{"issue":"13","key":"9125_CR116","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1158\/0008-5472.CAN-05-0749","volume":"65","author":"T Kelly","year":"2005","unstructured":"Kelly T, Suva LJ, Huang Y et\u00a0al (2005) Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res 65(13):5778\u20135784","journal-title":"Cancer Res"},{"issue":"18","key":"9125_CR117","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.1074\/jbc.M611259200","volume":"282","author":"Y Yang","year":"2007","unstructured":"Yang Y, Macleod V, Miao HQ et\u00a0al (2007) Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem 282(18):13326\u201313333","journal-title":"J Biol Chem"},{"issue":"11","key":"9125_CR118","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2006-08-043232","volume":"109","author":"K Mahtouk","year":"2007","unstructured":"Mahtouk K, Hose D, Raynaud P et\u00a0al (2007) Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma. Blood 109(11):4914\u20134923","journal-title":"Blood"},{"issue":"11","key":"9125_CR119","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/jbmr.2002.17.11.1921","volume":"17","author":"GD Roodman","year":"2002","unstructured":"Roodman GD (2002) Role of the bone marrow microenvironment in multiple myeloma. J Bone Miner Res 17(11):1921\u20131925","journal-title":"J Bone Miner Res"},{"issue":"14","key":"9125_CR120","first-page":"1361","volume":"1","author":"KC Anderson","year":"2002","unstructured":"Anderson KC, Dalton WS (2002) Synopsis of a research roundtable presented on cell signaling in myeloma: regulation of growth and apoptosis\u2013opportunities for new drug discovery. Mol Cancer Ther 1(14):1361\u20131365","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"9125_CR121","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","volume":"99","author":"F Zhan","year":"2002","unstructured":"Zhan F, Hardin J, Kordsmeier B et\u00a0al (2002) Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99(5):1745\u20131757","journal-title":"Blood"},{"issue":"2","key":"9125_CR122","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2002-10-3161","volume":"102","author":"K Tarte","year":"2003","unstructured":"Tarte K, Zhan F, De Vos J et\u00a0al (2003) Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood 102(2):592\u2013600","journal-title":"Blood"},{"issue":"4","key":"9125_CR123","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V99.4.1405","volume":"99","author":"PW Derksen","year":"2002","unstructured":"Derksen PW, Keehnen RM, Evers LM et\u00a0al (2002) Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood 99(4):1405\u20131410","journal-title":"Blood"},{"issue":"9","key":"9125_CR124","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V96.9.3139","volume":"96","author":"C Seidel","year":"2000","unstructured":"Seidel C, Borset M, Hjertner O et\u00a0al (2000) High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity. Blood 96(9):3139\u20133146","journal-title":"Blood"},{"issue":"8","key":"9125_CR125","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood-2002-04-1190","volume":"100","author":"T Standal","year":"2002","unstructured":"Standal T, Seidel C, Hjertner O et\u00a0al (2002) Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. Blood 100(8):3002\u20133007","journal-title":"Blood"},{"issue":"2","key":"9125_CR126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL et\u00a0al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2):165\u2013176","journal-title":"Cell"},{"issue":"6","key":"9125_CR127","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S et\u00a0al (2006) The molecular classification of multiple myeloma. Blood 108(6):2020\u20132028","journal-title":"Blood"},{"issue":"6","key":"9125_CR128","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood-2007-04-082495","volume":"110","author":"Y Yang","year":"2007","unstructured":"Yang Y, MacLeod V, Dai Y et\u00a0al (2007) The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood 110(6):2041\u20132048","journal-title":"Blood"},{"issue":"13","key":"9125_CR129","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1074\/jbc.M414217200","volume":"280","author":"A Naggi","year":"2005","unstructured":"Naggi A, Casu B, Perez M et\u00a0al (2005) Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. J Biol Chem 280(13):12103\u201312113","journal-title":"J Biol Chem"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-007-9125-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9125-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T10:05:24Z","timestamp":1630145124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-007-9125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,20]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["9125"],"URL":"https:\/\/doi.org\/10.1007\/s10585-007-9125-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,20]]}}}